Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR.
about
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Benefit of the addition of hor ...... of predicted and observed pCR.
@en
Benefit of the addition of hor ...... of predicted and observed pCR.
@nl
type
label
Benefit of the addition of hor ...... of predicted and observed pCR.
@en
Benefit of the addition of hor ...... of predicted and observed pCR.
@nl
prefLabel
Benefit of the addition of hor ...... of predicted and observed pCR.
@en
Benefit of the addition of hor ...... of predicted and observed pCR.
@nl
P2093
P2860
P1476
Benefit of the addition of hor ...... of predicted and observed pCR.
@en
P2093
Albane Frati
Carla Strina
Daniele Generali
Giovanni Allevi
Lajos Pusztai
Manuela Milani
Sergio Aguggini
Silvia Paola Corona
P2860
P2888
P356
10.1007/S00432-017-2574-4
P577
2018-01-17T00:00:00Z